Teva Pharmaceutical Industries Limited (DE:TEV)
NYSE:TEV
TEV Analyst Ratings
Strong Buy
9 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
TEV Stock 12 Month Forecast
Average Price Target
€36.94
▲(34.32% Upside)
| Highest Price Target€43.59 | Average Price Target€36.94 | Lowest Price Target€34.87 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Scotiabank
€34.87
Buy
26.79%
Upside
Reiterated
06/22/26
Jefferies
€34.87
Buy
26.79%
Upside
Reiterated
06/18/26
J.P. Morgan
―
Buy
―
Reiterated
06/15/26
Piper Sandler
€36.61
Buy
33.13%
Upside
Reiterated
06/10/26
Barclays
€33.12→€34.87
Buy
26.79%
Upside
Reiterated
05/06/26
Bank of America Securities
€34.87
Buy
26.79%
Upside
Reiterated
04/30/26
UBS
€31.38→€36.61
Buy
33.13%
Upside
Assigned
04/30/26
Goldman Sachs
€39.23→€43.59
Buy
58.49%
Upside
Reiterated
04/30/26
Truist Financial
€36.61→€39.23
Buy
42.64%
Upside
Assigned
04/30/26
Evercore ISI
―
Buy
―
Reiterated
11/26/25
Guggenheim
―
Hold
―
Reiterated
11/18/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Scotiabank
€34.87
Buy
26.79%
Upside
Reiterated
06/22/26
Jefferies
€34.87
Buy
26.79%
Upside
Reiterated
06/18/26
J.P. Morgan
―
Buy
―
Reiterated
06/15/26
Piper Sandler
€36.61
Buy
33.13%
Upside
Reiterated
06/10/26
Barclays
€33.12→€34.87
Buy
26.79%
Upside
Reiterated
05/06/26
Bank of America Securities
€34.87
Buy
26.79%
Upside
Reiterated
04/30/26
UBS
€31.38→€36.61
Buy
33.13%
Upside
Assigned
04/30/26
Goldman Sachs
€39.23→€43.59
Buy
58.49%
Upside
Reiterated
04/30/26
Truist Financial
€36.61→€39.23
Buy
42.64%
Upside
Assigned
04/30/26
Evercore ISI
―
Buy
―
Reiterated
11/26/25
Guggenheim
―
Hold
―
Reiterated
11/18/25
Best Analysts Covering Teva Pharmaceutical
3 Months
Success Rate
14/21 ratings generated profit
Average Return
+8.33%
Copying Ashwani Verma's trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +8.33% per trade.
1 Year
Success Rate
28/30 ratings generated profit
Average Return
+50.37%
Copying Jason Gerberry's trades and holding each position for 1 Year would result in 93.33% of your transactions generating a profit, with an average return of +50.37% per trade.
2 Years
Success Rate
29/30 ratings generated profit
Average Return
+80.75%
Copying Jason Gerberry's trades and holding each position for 2 Years would result in 96.67% of your transactions generating a profit, with an average return of +80.75% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
TEV Analyst Recommendation Trends
Rating
Feb 26
Mar 26
Apr 26
May 26
Jun 26
Strong Buy
0
0
0
0
0
Buy
30
27
23
20
19
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
30
27
23
20
19
Each month's total comprises the sum of three months' worth of ratings.
TEV Financial Forecast
TEV Stock Forecast FAQ
What is DE:TEV’s average 12-month price target, according to analysts?
Based on analyst ratings, Teva Pharmaceutical Industries Limited’s 12-month average price target is 36.94.
What is DE:TEV’s upside potential, based on the analysts’ average price target?
Teva Pharmaceutical Industries Limited has 34.32% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Teva Pharmaceutical Industries Limited a Buy, Sell or Hold?
Teva Pharmaceutical Industries Limited has a consensus rating of Strong Buy, which is based on 9 buy ratings, 0 hold ratings and 0 sell ratings.
What is Teva Pharmaceutical Industries Limited’s share price target?
The average share price target for Teva Pharmaceutical Industries Limited is 36.94. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €43.59 ,and the lowest forecast is €34.87. The average share price target represents 34.32% Increase from the current price of €27.5.
The highest analyst share price target is €43.59 ,and the lowest forecast is €34.87. The average share price target represents 34.32% Increase from the current price of €27.5.
What do analysts say about Teva Pharmaceutical Industries Limited?
Teva Pharmaceutical Industries Limited’s analyst rating consensus is a Strong Buy. This is based on the ratings of 9 Wall Streets Analysts.
How can I buy shares of Teva Pharmaceutical Industries Limited?
To buy shares of DE:TEV, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.